Skip to main content Scroll Top

How and when to engage with Industry

pharma_ind_small

In this seminar Rob will cover tips on how and when to engage with industry, and explain the benefits of building better bridges with industry. Rob will also cover the relevant funding sources, organisations and initiatives that encourage industry enabling upskilling of students and researchers for the broader marketplace, and how positive engagement may bring about new sources of revenue streams and create a way to support your innovations to come to market.

•Why engage with industry?

•The benefits of engaging with industry

•An overview of the current landscape and future directions in industry engagement

•Tips and strategies on engaging with industry

•Sourcing funding to assist with engagement

Meet your Presenter: Rob Crombie

Rob Crombie is currently the VIC/TAS State Lead for i4 Connect delivering the Federal Governments Accelerating Commercialisation programme through his role as Managing Director of Concept2Clinic Consulting, a specialist professional services company looking to turn smart innovation into commercial ventures.

Rob’s has had previous roles as CEO of VC backed QUE Oncology Incorporated as well as the founding CEO of ASX-listed Prescient Therapeutics, in-licensing early stage drug candidates from Universities including Yale and Emory University and building value by advancing these assets through company sponsored clinical trials.

Rob also played a key role as Head of Melbourne Operations at Arana Therapeutics taking the company from CSIRO spin-out through an IPO and merger to Arana’s final $318M upfront cash sale to US-based Cephalon Incorporated.

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.